1. Heinz T, Perfect J, Schell W, Ritter E, Ruff G, Serafin D. Soft-tissue fungal infections. Surgical management of 12 Immunocompromised patients. Plast Reconstr Surg. 1996. 97:1391–1399.
Article
2. Murakawa GJ, Harvell JD, Lubitz P, Schnoll S, Lee S, Berger T. Cutaneous aspergillosis and acquired immunodeficiency syndrome. Arch Dermatol. 2000. 136:365–369.
Article
3. Gupta M, Weinberger B, Whitley-Williams PN. Cutaneous aspergillosis in a neonate. Pediatr Infect Dis J. 1996. 15:464–465.
Article
4. Smolinski KN, Shah SS, Honig PJ, Yan AC. Neonatal cutaneous fungal infections. Curr Opin Pediatr. 2005. 17:486–493.
Article
5. Herron MD, Vanderhooft SL, Byington C, King JD. Aspergillosis in a 24-week newborn: a case report. J Perinatol. 2003. 23:256–259.
6. Goel R, Wallace ML. Pseudoepitheliomatous hyperplasia secondary to cutaneous Aspergillus. Am J Dermatopathol. 2001. 23:224–226.
Article
7. Roilides E, Farmaki E. Human immunodeficiency virus Infection and cutaneous aspergillosis. Arch Dermatol. 2000. 136:412–414.
Article
8. Colwell AS, Mentzer SJ, Vargas SO, Orgill DP. The role of muscle flaps in pulmonary aspergillosis. Plast Reconstr Surg. 2003. 111:1147–1150.
Article
9. Salerno CT, Ouyang DW, Pederson TS, Larson DM, Shake JP, Johnson EM, Maddaus MA. Surgical therapy for pulmonary aspergillosis in immunocompromised patients. Ann Thorac Surg. 1998. 65:1415–1419.
Article
10. Anderson LL, Giandoni MB, Keller RA, Grabski WJ. Surgical wound healing complicated by aspergillus infection in a nonimmunocompromised host. Dermatol Surg. 1995. 21:799–801.
Article